Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Women's Health

Font Size

FDA OKs New Bacterial Vaginosis Drug

Tindamax Already in Use for Treatment of Trichomoniasis
WebMD Health News
Reviewed by Louise Chang, MD

May 24, 2007 -- The FDA has approved the antibacterial drug Tindamax to treat bacterial vaginosis, the most common vaginal infection in women of childbearing age.

Bacterial vaginosis is linked to an imbalance in vaginal bacteria, with an overgrowth of "bad" bacteria vs. "good" bacteria, notes the CDC.

Tindamax is the first new oral treatment for bacterial vaginosis in a decade, according to a news release issued today by Mission Pharmacal, which makes Tindamax.

The FDA first approved Tindamax in 2004 for treating three other infections:

According to Mission Pharmacal, the FDA approved Tindamax for the treatment of bacterial vaginosis based on a clinical trial of 235 women with bacterial vaginosis.

The researchers split the women into three groups. One group took four Tindamax tablets daily for two days. Another group took two Tindamax pills daily for five days. The third group took an inactive pill (placebo).

Both Tindamax doses were superior to the placebo, with cure rates of 27% for the two-day Tindamax treatment, 37% for the five-day Tindamax treatment, and 5% for the placebo.

The FDA approved both Tindamax doses for bacterial vaginosis treatment.

Mission Pharmacal notes "minimal" side effects in Tindamax trials, including metallic taste and nausea.

Today on WebMD

hands on abdomen
Test your knowledge.
womans hand on abdomen
Are you ready for baby?
birth control pills
Learn about your options.
Is it menopause or something else?
woman in bathtub
bp app on smartwatch and phone
estrogen gene

Send yourself a link to download the app.

Loading ...

Please wait...

This feature is temporarily unavailable. Please try again later.


Now check your email account on your mobile phone to download your new app.

Blood pressure check
hot water bottle on stomach
Attractive young woman standing in front of mirror